Laparoendoscopic single-site surgery is safe, feasible in pediatric patients, according to study
March 1st 2010Researchers enumerate the benefits of LESS as improved cosmesis, reduction in iatrogenic bowel injury, reduced risk of visceral and vascular injuries associated with port placement, lower risk of wound infections and incisional hernias, and possible cost reductions derived from the use of a single port.
Artificial urinary sphincter placement in the irradiated post-radical prostatectomy patient
March 1st 2010Although mesh slings have become increasingly commonplace for the treatment of mild male stress urinary incontinence, the artificial urinary sphincter remains the gold standard of treatment for managing severe post-prostatectomy incontinence.
Use of testosterone therapy in hypogonadal men with prostate cancer
March 1st 2010Just a few years ago, it would have been unthinkable to offer testosterone therapy (TTh) to men with a history of prostate cancer. Yet several changes have occurred to make TTh a reasonable treatment option in men who are symptomatic from testosterone deficiency.
Robotic renal surgery: Advantages and technical considerations
March 1st 2010With a foundation of robotic surgery investigated and established for radical prostatectomy, urologists have now focused on expanding robotic applications to the upper tract. The most common examples are robotic partial nephrectomy and robotic pyeloplasty.
Dr. Blute named director of UMass Cancer Center of Excellence
February 25th 2010Michael Blute, MD, has joined UMass Memorial Health Care and UMass Medical School, Worcester, MA, as director of the Cancer Center of Excellence, professor of surgery, and interim director of the division of urology in the department of surgery.
Majority of laparoscopic surgeons experiencing occupational injuries
February 25th 2010A majority?87%?of laparoscopic surgeons has experienced physical symptoms or discomfort, a new survey by University of Maryland, Baltimore researchers has found. This was especially true among those with high-case volumes, according to the results.
Scientists identify genetic variant associated with aggressive PCa
February 11th 2010Genetic information may one day be used in combination with other factors to guide treatment decisions for aggressive prostate cancer due to the recent detection of a genetic variant associated with the disease, data from a recent study suggest.
Study: Vaccine approach extends life of metastatic prostate Ca patients
February 11th 2010Patients with metastatic prostate cancer who received a vaccine engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, according to researchers at Dana-Farber Cancer Institute, Boston and affiliated organizations.
Multi-group advisory: ADT can increase cardiac risk factors
February 11th 2010Androgen deprivation therapy (ADT) can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death, although the relationship between ADT and heart attack or cardiac death has not been definitively established, according to a science advisory from a multi-organization group.